EcoDrugPlus

Protein Kinase C, Delta B

Ensembl ID : ENSATEG00000017519
Gene Symbol: PRKCDB
2 Cross references
204 Possible Orthologues:

Protein Kinase C, Epsilon A

Ensembl ID : ENSATEG00000002634
Gene Symbol: PRKCEA
2 Cross references
250 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSATEG00000015517
Gene Symbol: PRKCHA
3 Cross references
223 Possible Orthologues:

Protein Kinase C, Iota

Ensembl ID : ENSATEG00000022084
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSATEG00000022118
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSATEG00000001636
Gene Symbol: PRKD3
3 Cross references
207 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSATEG00000007100
Gene Symbol: PRKD3
2 Cross references
218 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta, B

Ensembl ID : ENSATEG00000005837
Gene Symbol: PTK2BB
3 Cross references
196 Possible Orthologues:

Protein Tyrosine Kinase 2aa

Ensembl ID : ENSATEG00000012064
Gene Symbol: PTK2AA
2 Cross references
241 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSATEG00000003929
Gene Symbol: PTPN11A
3 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSATEG00000023608
Gene Symbol: PTPRB
2 Cross references
193 Possible Orthologues:

Protein-Serine O-Palmitoleoyltransferase Porcupine-Like

Ensembl ID : ENSATEG00000000320
Gene Symbol: LOC113167487
2 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).